Clinical Trial

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Study Description

Arsenic, Disordered Glucose Homeostasis and Atherosclerosis

Investigators will recruit 250 subjects; Group A will consist of 100 prediabetic patients with an A1c of 5.7%-6.4%. Group B will consist of 100 patients with uncontrolled T2D defined as either a) an A1c of 6.5%-7.9% without diabetes medications or b) an A1c a?Y 8.0% with or without diabetes medications. Group C will include 50 participants without T2D or known cardiovascular disease to serve as control comparisons.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Arsenic Exposure, Disordered Glucose Homeostasis and Atherosclerosis Protocol

Clinical Trial ID

NCT02759289

ParticipAid ID

6dBXQa